Scalpel Weekly News

Week of: February 08, 2016

IN THE NEWS


Drug Approved to Treat Chronic Hepatitis C

On January 28, 2016, the FDA approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. Zepatier is marketed by Merck & Co. Inc. based in Whitehouse Station, New Jersey. Click title to continue reading...


 
MEDICAL ALERTS


Test Strips Give Falsely Low Glucose Levels; Class I Recall

January 28, 2016, the FDA initiated a Class I recall of SPOTCHEM II Basic PANEL-1 Reagent Test Strips and SPOTCHEM II Glucose Reagent Test Strips. This Class I recall is the most serious type of recall as they involve situations in which there is a reasonable probability that use of the product will cause serious adverse health consequences or death. Click title to continue reading...



Leaking Containers and Particulate Matter Require Recall of Baxter IV Solutions

On January 27, 2016, the FDA identified the recall of Baxter IV solutions as a Class I recall, which is the most serious type of recall when there is a reasonable probability that use of the product will cause serious adverse health consequences or death. Click title to continue reading...



Expanding Zika Outbreak Linked to Microcephaly and Neurologic Abnormalities

The CDC, on January 15, 2016, issued a travel alert (Level 2-Practice Enhanced Precautions) for people traveling to regions and certain countries where Zika virus transmission is ongoing: Brazil, Colombia, El Salvador, French Guiana, Guatemala, Haiti, Honduras, Martinique, Mexico, Panama, Paraguay, Suriname, Venezuela, and the Commonwealth of Puerto Rico. On January 22, 2016, the CDC added the following destinations to the Zika virus travel alerts: Barbados, Bolivia, Ecuador, Guadeloupe, Saint Martin, Guyana, Cape Verde, and Samoa. On January 26, 2016, the CDC added two more destinations to the Zika virus alerts, United States Virgin Islands and Dominican Republic. Click title to continue reading...


  CASE ALERTS


Heart Attack During Finger Amputation; Conflicting Wrongful Death Evidence

A 54-year-old man went to the hospital to have the tip of his right index finger amputated in what was intended to be an outpatient procedure. At the time of his surgery, the man had multiple health problems including cardiomyopathy, an internal heart defibrillator, end-stage renal failure, and a fistula to assist with his dialysis. He had a past medical history of heart disease and peripheral vascular disease. Click title to continue reading...



Life Care Planner and Standard of Care Expert Excluded; Discovery Violations

An orthopedic surgeon examined a man reporting left knee pain with movement. The orthopedic surgeon referred the man to a nurse practitioner in the neurology clinic. The man was first seen by the nurse practitioner at the neurology clinic about two weeks later. Over the course of several more months, the man attended additional appointments with the nurse practitioner about eight months after his first appointment. Later, the nurse practitioner referred the man to a neurologist. Click title to continue reading...



Fibromyalgia Evidence Insufficient for Disability Retirement Benefits

A 56-year-old woman employed by the state of Kentucky filed for disability retirement benefits. She alleged a disability due to fibromyalgia, clinical depression, carpal tunnel syndrome, and anxiety disorder. The medical review board denied her application two times. The woman appealed after the second denial. Click title to continue reading...


FEATURE


Motion: Exclude Infertility Expert

As a special feature to our Premium subscribers we have included this feature containing an illustrative Motion to exclude an infertility expert in a dissolution action involving a woman’s in vitro fertilization to preserve her fertility in light of her age and cancer treatment. The embryos were cryopreserved. Click title to continue reading...